论文部分内容阅读
ＤｕＰｏｎｔ公司的非核苷类逆转录酶抑制剂Ｅｆａｖｉｒｅｎｚ目前已获得美国ＦＤＡ的批准，用于治疗成人或儿童的ＨＩＶ感染和ＡＩＤＳ。每天服用１次，食物对其无影响，可与蛋白酶抑制剂和／或核苷类逆转录酶抑制剂合用。曾有报道，５０％的病人服用后出现神经系统症状...
Efavirenz, a non-nucleoside reverse transcriptase inhibitor from DuPont, has now received FDA approval for the treatment of HIV infection and AIDS in adults and children. Take it once daily, food has no effect on it and can be used with protease inhibitors and / or nucleoside reverse transcriptase inhibitors. It has been reported that 50% of patients with nervous system symptoms after taking ...